TLDR The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.
The 2019 review addressed the multifaceted nature of Polycystic Ovarian Syndrome (PCOS), affecting 6-10% of women of reproductive age, and its impact on various health aspects including reproductive, metabolic, dermatologic, and psychiatric health. It emphasized the unknown pathogenesis of PCOS and the focus on symptom management for treatment. The review covered the diagnostic criteria for PCOS, such as the Rotterdam criteria, and management strategies that include regulating menstrual cycles and addressing mental health issues. It also discussed the cardiometabolic risks like insulin resistance and mood disorders associated with PCOS. Advances in understanding the role of the gut microbiome, genetic and epigenetic factors in PCOS were mentioned, along with novel treatments being explored, including diabetes medications and nutritional supplements. The review concluded that despite progress, further research is essential for improving the long-term health outcomes for individuals with PCOS.
16 citations,
May 2019 in “Hormone and Metabolic Research” Selenium might help with insulin resistance and cholesterol in PCOS, but more research is needed to confirm its benefits.
16 citations,
December 2017 in “Journal of Pediatric and Adolescent Gynecology” Different diagnostic criteria greatly affect PCOS diagnosis rates in teenagers.
343 citations,
October 2015 in “Endocrine Practice” The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.
46 citations,
June 2015 in “Fertility and Sterility” Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.
253 citations,
March 2006 in “The Journal of Clinical Endocrinology and Metabolism” Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.
January 2022 in “IntechOpen eBooks” Some lesser-known causes of PCOS include autoimmune issues, genetic mutations, and changes in the body's microbiome.
Women with PCOS are at higher risk for gum disease, and managing shared risk factors can help both conditions.
1 citations,
January 2023 in “Metabolites” Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.
2 citations,
May 2023 in “Current Nutrition Reports” Eating a Mediterranean diet and taking certain supplements may improve symptoms of PCOS.
January 2024 in “Medicina” Statins may help treat PCOS by lowering androgen levels and improving cholesterol.